Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Biol Trace Elem Res ; 193(2): 483-493, 2020 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-31025242

RESUMO

We aimed to investigate the protective effect of alpha lipoic acid (ALA), a powerful antioxidant, against oxidative kidney damage induced by iron overload in rats. Male Wistar albino rats were separated into groups: control (n = 7), ALA (100 mg/kg (n = 7), iron sucrose (IS) (40 mg/kg) (n = 7), and IS + ALA (40 mg/kg IS administration followed by 100 mg/kg ALA) (n = 7). IS and ALA were injected weekly for 4 weeks via the tail vein. Blood and kidneys were collected at sacrification on day 29. Serum creatinine and iron levels were analyzed. Tubular injury and iron deposits were evaluated histopathologically. Additionally, iron, malondialdehyde (MDA), superoxide dismutase (SOD), catalase, and glutathione (GSH) levels and mRNA expressions of the subunits of NADPH oxidase, known as NOX4 and p22phox, tumor necrosis factor (TNF)-α, kidney injury molecule-1 (KIM-1), and also p38 MAPK signaling in the kidneys, were evaluated biochemically. In the IS group, serum creatinine and iron level, tubular dilation, and loss of brush border in the kidneys were significantly higher than those of the control. Although those changes were reduced by ALA, the differences were not statistically significant. However, ALA reduced significantly MDA level and increased SOD activity in the kidney during IS administration. ALA also significantly reduced mRNA expressions of NOX4 and p22phox induced by IS, which was parallel to significant decreases of TNF-α and KIM-1 mRNA expressions. Moreover, ALA could suppress the activation of p38 MAPK during IS administration. In conclusion, ALA may be an effective strategy to attenuate in IS-induced oxidative kidney injury.


Assuntos
Nefropatias/prevenção & controle , Rim/efeitos dos fármacos , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , NADPH Oxidase 4/antagonistas & inibidores , Ácido Tióctico/farmacologia , Proteínas Quinases p38 Ativadas por Mitógeno/antagonistas & inibidores , Animais , Moléculas de Adesão Celular/genética , Moléculas de Adesão Celular/metabolismo , Expressão Gênica/efeitos dos fármacos , Sobrecarga de Ferro/complicações , Rim/metabolismo , Nefropatias/etiologia , Nefropatias/metabolismo , Masculino , NADPH Oxidase 4/genética , NADPH Oxidase 4/metabolismo , Substâncias Protetoras/farmacologia , Ratos Wistar , Fator de Necrose Tumoral alfa/genética , Fator de Necrose Tumoral alfa/metabolismo , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
3.
Curr Drug Deliv ; 14(3): 394-405, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-27480119

RESUMO

OBJECTIVES: Nitrofurantoin is widely used in the prophylaxis of urinary-tract infections. The aim of this study was to develop and characterize innovative transdermal formulations of nitrofurantoin, to increase the patient compliance and decrease the adverse effects such as nausea and vomiting which limit the drug use in long-term. METHODS: Nitrofurantoin loaded microemulsion, gel (hydrogel, lipogel and DMSO gel) and film formulations were prepared and characterized via several parameters. Ex-vivo drug permeation studies were performed to determine the amount of drug permeated through the rat skin. In in-vivo studies, in order to detect nitrofurantoin in urine, the selected formulations were applied to male Wistar rats transdermally. Also, skin irritation tests (transepidermal water loss and erythema) were performed. RESULTS: All nitrofurantoin loaded formulations were prepared successfully and were stable at +4°C for 3 months. 13%, 16%, 32.5%, 36.5% and 39% of drugs permeated through the rat skin in the 168th hour for hydrogel, lipogel, film, microemulsion and DMSO gel, respectively. Only with film and DMSO gel formulations, nitrofurantoin was detected in urine. Transepidermal water loss was increased compared to basal level in film type formulations (p<0.05). However, in erythema experiments there was no difference (p>0.05). CONCLUSION: There is no approved transdermal formulation of nitrofurantion on the market. Therefore, the prepared film formulations could be an alternative due to their high penetration through the rat skin, the presence of nitrofurantoin in urine and because they cause no irritation on the skin.


Assuntos
Nitrofurantoína/administração & dosagem , Absorção Cutânea , Administração Cutânea , Animais , Emulsões , Géis , Hidrogéis , Masculino , Ratos , Ratos Wistar , Pele
4.
Turkiye Parazitol Derg ; 38(1): 32-6, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24659699

RESUMO

OBJECTIVE: The well-known and common infestation caused by Pediculus humanus capitis is an important public health and a social issue in many communities in the world. The aim of this study was to compare the head louse infestation rate in two schools having pupils from different socio-economic levels in the city center of Izmir. METHODS: The pupils aged between 6 and 11 years, were screened for the presence of eggs and nymph/adult lice using a fine-tooth head louse comb. RESULTS: A total of 88 and 126 pupils from the schools with low and medium socio-economic level were screened and 24 (27.2%) and 5 (3.96%) of them were found to be positive for head lice, respectively. Overall, the infestation rate among girls was 3.14 times higher than in boys. CONCLUSION: Head louse infestation is a significant public health problem among primary schools. Increasing the knowledge about pediculosis and self-hygiene would be helpful in successfully reducing head louse infestation in the school setting. School authorities must encourage the parents to look for head lice routinely and a "school nurse" system is needed for effective head louse control in the schools.


Assuntos
Infestações por Piolhos/epidemiologia , Pediculus/fisiologia , Animais , Criança , Feminino , Humanos , Higiene , Infestações por Piolhos/economia , Infestações por Piolhos/parasitologia , Masculino , Prevalência , Instituições Acadêmicas , Fatores Sexuais , Fatores Socioeconômicos , Turquia/epidemiologia , População Urbana
5.
Drug Chem Toxicol ; 34(1): 53-60, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-20954804

RESUMO

We planned this study in order to investigate the effects of theophylline on cardiovascular parameters in an anaesthetized rat model of amitriptyline toxicity. In the preliminary study, we tested theophylline as 1 mg/kg of bolus, followed by a 0.5-mg/kg infusion. Toxicity was induced by the infusion of 0.94 mg/kg/min of amitriptyline up to the point of a 40-45% inhibition of mean arterial pressure (MAP). The rats were randomized to two groups: a group of 5% dextrose bolus followed by 5% dextrose infusion, and another group with theophylline bolus followed by infusion. Amitriptyline caused a significant decrease in MAP and prolongation in QRS; however, it did not alter heart rate (HR). When compared to the dextrose group, theophylline administration increased MAP, shortened prolonged QRS duration, and increased HR (P < 0.05, respectively). There was no statistically significant difference in the results of arterial blood-gas analyses among the groups (P > 0.05). Bolus doses followed by a continuous infusion of theophylline were found to be effective in reversing the hypotension and QRS prolongation seen in amitriptyline toxicity. One of the possible explanations of this beneficial effect is nonselective adenosine antagonism of theophylline. Further studies are needed to reveal the exact mechanism of the observed effect.


Assuntos
Amitriptilina/toxicidade , Antídotos/uso terapêutico , Antagonistas de Receptores Purinérgicos P1/uso terapêutico , Teofilina/uso terapêutico , Amitriptilina/intoxicação , Animais , Antídotos/administração & dosagem , Gasometria , Pressão Sanguínea/efeitos dos fármacos , Dióxido de Carbono/sangue , Modelos Animais de Doenças , Esquema de Medicação , Eletrocardiografia , Glucose/administração & dosagem , Glucose/uso terapêutico , Frequência Cardíaca/efeitos dos fármacos , Infusões Intravenosas , Injeções Intravenosas , Masculino , Oxigênio/sangue , Intoxicação/sangue , Intoxicação/tratamento farmacológico , Intoxicação/fisiopatologia , Antagonistas de Receptores Purinérgicos P1/administração & dosagem , Ratos , Ratos Wistar , Teofilina/administração & dosagem , Fatores de Tempo
6.
Drug Chem Toxicol ; 33(3): 233-7, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-20429795

RESUMO

OBJECTIVE: We investigated the effects of adenosine receptor antagonists on survival rates in a mouse model of amitriptyline poisoning. MATERIALS AND METHODS: In the preliminary study, amitriptyline was given at doses of 75, 100, and 125 mg/ kg to mice intraperitoneally (i.p.; n = 20 for each dose) to determine the lethal dose at 50% (LD(50)). Different doses (1, 3, and 5 mg/kg) of DPCPX (selective adenosine A(1) antagonists, n = 10 for each dose, total n = 30) or CSC (selective adenosine A(2a) antagonists, n = 10 for each dose, total n = 30) were given i.p. to find the nonlethal dose. After the administration of the LD(50) dose of amitriptyline (125 mg/kg), mice were treated with DPCPX (3 mg/kg), CSC (3 mg/kg), saline, or DMSO (dimethyl sulfoxide) (n = 25 for each group). Mice were observed during a 24-hour period. RESULTS: Kaplan-Meier estimates of the 24-hour survival rate was 52% (13/25) for saline and 68% (17/25), 52% (13/25), and 40% (10/25) for the DPCPX, CSC, and DMSO groups, respectively. There was no statistically significant difference in survival rates among the groups (P > 0.05). CONCLUSIONS: Adenosine antagonists failed to increase the survival rates of amitriptyline-poisoned mice. Further studies are needed with repeated doses of adenosine antagonists.


Assuntos
Antagonistas do Receptor A1 de Adenosina , Antagonistas do Receptor A2 de Adenosina , Amitriptilina/intoxicação , Antidepressivos Tricíclicos/intoxicação , Xantinas/farmacologia , Animais , Relação Dose-Resposta a Droga , Estimativa de Kaplan-Meier , Dose Letal Mediana , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Distribuição Aleatória , Receptor A1 de Adenosina/metabolismo , Receptor A2A de Adenosina/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...